Sara Sánchez Molina

Sara Sánchez Molina

Investigador

Sara Sánchez-Molina holds degrees in Chemistry (1999) and Biochemistry (2001) from the University of Barcelona. From early 2002 to late 2006, she completed her doctoral thesis under the supervision of Dr. Marian Martínez Balbás in the Molecular Signaling and Chromatin group at the Institute of Molecular Biology of Barcelona (CSIC). During this period, she studied the role of histone modifications in cellular transformation induced by the Ras oncogene.

In 2007, she joined the Chromatin Dynamics group led by Dr. Peter Becker at the Adolf Butenandt Institut, Ludwig Maximilian University of Munich (Germany), where she was employed as a postdoctoral researcher until 2011. During this time, she focused on elucidating the role of ISWI family chromatin remodeling complexes and their function in signaling DNA damage induced by X-rays, UV rays, and replication stress.

In 2013, she joined the Sarcoma and Neuroblastoma group as a postdoctoral researcher. Within this group, she has developed various lines of research focused on the analysis of chromatin and the Polycomb complex in Ewing's sarcoma and rhabdomyosarcoma. She currently leads the Pediatric Sarcoma Epigenetics team. Her main objective is to propose new treatments for pediatric patients with sarcomas with a poor prognosis based on an in-depth understanding of the dysregulation of molecular mechanisms associated with chromatin. She has supervised seven doctoral theses and has participated in various national and international projects and conferences.

sara.sanchezm@sjd.es

Professional network profiles

Last Publications

More Publications

Projects

Project name:
Epigenetic disruption of EWSR1-FLI1 condensates
Leader
Sara Sánchez Molina
Funding entities:
Bone Cancer Research Trust
Code
10024
Starting - finishing date:
2025 - 2028
Project name:
Disrupción de enhancers: la nueva generación de terapia epigenética en el sarcoma de Ewing
Leader
Jaume Mora Graupera, Sara Sánchez Molina
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
PI24/00804
Starting - finishing date:
2025 - 2027
Project name:
Influencia del contexto epigenético en la edad como factor pronóstico en Ewing Sarcoma
Leader
Jaume Mora Graupera
Funding entities:
Instituto de Salud Carlos III (ISCIII)
Code
PI20/00179
Starting - finishing date:
2021 - 2023
More projects

News

See All news

More activities

More activities